DexCom Inc/ US2521311074 /
20/09/2024 22:00:00 | Diferencia -1.4900 | Volumen | Bid0:58:33 | Ask0:58:33 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
70.4300USD | -2.07% | 7.71 millones Volumen de negocios: 431.36 millones |
70.1500Volumen de oferta: 300 | 70.4300Tamaño/ Volumen/ Formato de Ask: 200 | 28.22 mil millonesUSD | - | 50.31 |
Newsfile Corp
3:09
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Sage Therapeutics, Inc. Investors to Secur...
Newsfile Corp
3:06
Important October 25, 2024 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Methode Ele...
Newsfile Corp
1:41
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Impo...
Newsfile Corp
1:10
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Coinbase Global, Inc. Investors to Secure Coun...
Newsfile Corp
1:00
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Agenus Inc. Investors to Secure Counsel Before Imp...
Newsfile Corp
0:58
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Befo...
Newsfile Corp
0:16
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Iris Energy Limited Investors to Inquire About Securities ...
Newsfile Corp
21/09
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Spire Global, Inc. Investors to Secure Counsel Before Im...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página